Tumor-Associated Immune Parameters for Personalized Patient Care

See allHide authors and affiliations

Science Translational Medicine  04 Dec 2013:
Vol. 5, Issue 214, pp. 214fs42
DOI: 10.1126/scitranslmed.3007942

You are currently viewing the abstract.

View Full Text


The implementation of a robust technology adapted to clinical practice for the evaluation of the tumor-immune infiltrate is required to exploit its prognostic and theranostic value (Robins et al., this issue).

View Full Text